Randomized Drug Interaction Study of RO4929097 for Advanced Solid Tumors.

Trial Profile

Randomized Drug Interaction Study of RO4929097 for Advanced Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs RG 4733 (Primary) ; Dextromethorphan; Ketoconazole; Midazolam; Omeprazole; Rifampicin; Tolbutamide
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jun 2012 Planned end date changed from 1 Oct 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 14 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 16 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top